| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth.
|
Genes Dev
|
2004
|
1.30
|
|
2
|
Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.
|
Hum Mol Genet
|
2013
|
1.15
|
|
3
|
Tumor galectinology: insights into the complex network of a family of endogenous lectins.
|
Glycoconj J
|
2004
|
1.11
|
|
4
|
Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.03
|
|
5
|
Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3.
|
Mitochondrion
|
2013
|
1.02
|
|
6
|
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.
|
PLoS Genet
|
2012
|
1.01
|
|
7
|
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T.
|
J Mol Endocrinol
|
2006
|
1.00
|
|
8
|
PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice.
|
Genetics
|
2006
|
1.00
|
|
9
|
Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.
|
Endocrinology
|
2005
|
0.99
|
|
10
|
Short-term exposure to low-carbohydrate, high-fat diets induces low bone mineral density and reduces bone formation in rats.
|
J Bone Miner Res
|
2010
|
0.96
|
|
11
|
Cortical bone loss in androgen-deficient aged male rats is mainly caused by increased endocortical bone remodeling.
|
J Bone Miner Res
|
2008
|
0.95
|
|
12
|
Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice.
|
Anat Embryol (Berl)
|
2002
|
0.95
|
|
13
|
IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis.
|
Int J Cancer
|
2009
|
0.95
|
|
14
|
Insulin glargine and NPH insulin increase to a similar degree epithelial cell proliferation and aberrant crypt foci formation in colons of diabetic mice.
|
Horm Cancer
|
2010
|
0.94
|
|
15
|
Transgenic mice reveal novel activities of growth hormone in wound repair, angiogenesis, and myofibroblast differentiation.
|
J Biol Chem
|
2004
|
0.93
|
|
16
|
Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight.
|
Endocrinology
|
2006
|
0.93
|
|
17
|
Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos.
|
Biol Reprod
|
2003
|
0.91
|
|
18
|
Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I).
|
J Biol Chem
|
2011
|
0.90
|
|
19
|
Metabolic adaptations in the liver of born long-distance running mice.
|
Med Sci Sports Exerc
|
2013
|
0.87
|
|
20
|
Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis.
|
Endocrinology
|
2006
|
0.87
|
|
21
|
Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2.
|
Am J Physiol Endocrinol Metab
|
2010
|
0.87
|
|
22
|
The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop.
|
FASEB J
|
2003
|
0.86
|
|
23
|
Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats.
|
Endocrinology
|
2011
|
0.86
|
|
24
|
Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I.
|
Endocrinology
|
2008
|
0.85
|
|
25
|
Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice.
|
Endocrinology
|
2011
|
0.84
|
|
26
|
Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
|
Brain
|
2014
|
0.82
|
|
27
|
Functional consequences of IGFBP excess-lessons from transgenic mice.
|
Pediatr Nephrol
|
2004
|
0.81
|
|
28
|
A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma.
|
Steroids
|
2010
|
0.80
|
|
29
|
Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanisms.
|
Cancer Res
|
2004
|
0.80
|
|
30
|
Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
|
Growth Horm IGF Res
|
2012
|
0.79
|
|
31
|
Systems biology and bioinformatics in aging research: a workshop report.
|
Rejuvenation Res
|
2012
|
0.79
|
|
32
|
Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
|
Exp Biol Med (Maywood)
|
2009
|
0.79
|
|
33
|
IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment.
|
J Carcinog
|
2006
|
0.79
|
|
34
|
Diethylnitrosamine induces long-lasting re-expression of insulin-like growth factor II during early stages of liver carcinogenesis in mice.
|
Growth Horm IGF Res
|
2002
|
0.79
|
|
35
|
Dynamics of Fat Mass in DUhTP Mice Selected for Running Performance - Fat Mobilization in a Walk.
|
Obes Facts
|
2015
|
0.78
|
|
36
|
Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity.
|
Amyotroph Lateral Scler
|
2012
|
0.78
|
|
37
|
Phenotype selection reveals coevolution of muscle glycogen and protein and PTEN as a gate keeper for the accretion of muscle mass in adult female mice.
|
PLoS One
|
2012
|
0.78
|
|
38
|
Lifelong obesity in a polygenic mouse model prevents age- and diet-induced glucose intolerance- obesity is no road to late-onset diabetes in mice.
|
PLoS One
|
2013
|
0.78
|
|
39
|
High-fertility phenotypes: two outbred mouse models exhibit substantially different molecular and physiological strategies warranting improved fertility.
|
Reproduction
|
2014
|
0.76
|
|
40
|
Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.
|
Acta Neuropathol
|
2015
|
0.76
|
|
41
|
Decreased p44/42 mitogen-activated protein kinase phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice.
|
Endocrinology
|
2008
|
0.76
|
|
42
|
In silico approaches and the role of ontologies in aging research.
|
Rejuvenation Res
|
2013
|
0.75
|
|
43
|
Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.
|
J Cell Commun Signal
|
2015
|
0.75
|
|
44
|
Molecular biological fingerprinting of human lectin expression by RT-PCR.
|
Methods Enzymol
|
2003
|
0.75
|